Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 56 (4) , 604-611
- https://doi.org/10.1016/j.jaad.2007.01.009
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Recognition, diagnosis, and treatment of primary focal hyperhidrosisJournal of the American Academy of Dermatology, 2004
- US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national surveyJournal of the American Academy of Dermatology, 2004
- Long-Term Quantitative Benefits of Botulinum Toxin Type A in the Treatment of Axillary HyperhidrosisDermatologic Surgery, 2002
- Long-Term Efficacy and Quality of Life in the Treatment of Focal Hyperhidrosis with Botulinum Toxin ADermatologic Surgery, 2002
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlledBMJ, 2001
- Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)New England Journal of Medicine, 2001
- Botulinum toxin-a possible new treatment for axillary hyperhidrosisClinical and Experimental Dermatology, 1996
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994
- A sharper Bonferroni procedure for multiple tests of significanceBiometrika, 1988
- Tap water iontophoresis in palmoplantar hyperhidrosisBritish Journal of Dermatology, 1977